Liam Simms

Imperial Brands (United Kingdom)

Papers

1

Total Citations

85

H-Index

1

About

Dr. Liam Simms is a leading toxicologist whose work has been instrumental in reshaping how we assess the respiratory health risks of nicotine products. His primary research focuses on developing advanced, human-relevant in vitro models to replace traditional animal testing, with a particular emphasis on comparing the toxicological profiles of conventional cigarettes and emerging e-cigarette technologies. His landmark 2019 study, “Toxicological comparison of cigarette smoke and e-cigarette aerosol using a 3D in vitro human respiratory model,” has garnered 85 citations and stands as a cornerstone in the field. This work pioneered the use of a sophisticated three-dimensional human respiratory tissue model to demonstrate that e-cigarette aerosol induces significantly less cellular damage and inflammation than cigarette smoke, providing critical data for harm reduction debates. Dr. Simms’ contributions are pivotal for regulatory science, offering a robust, ethical framework for evaluating product safety. His dedication to replacing, reducing, and refining animal testing has not only advanced public health research but also set a new standard for toxicological assessment in the 21st century.

Research Focus

Key Achievements

1
H-Index
1
Papers
85
Total Citations
85
Avg Citations/Paper
🏆 Most Cited Paper
Toxicological comparison of cigarette smoke and e-cigarette aerosol using a 3D in vitro human respiratory model
85 citations · 2019
📈 Most Prolific Year: 2019 (1 Papers)
🤝 Key Collaborators: 5
🏛 Institutions: Imperial Brands (United Kingdom)

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago